BRIEF published on 04/07/2026 at 18:05, 1 month ago Oxurion postpones its Annual General Meeting Pharmaceutical Digital Assets General Assembly Report Oxurion
BRIEF published on 04/07/2026 at 18:05, 1 month ago Oxurion reporte son assemblée générale annuelle des actionnaires Calendrier Financier Assemblée Générale Des Actionnaires Risques D'investissement Oxurion Externalisation Pharmaceutique
PRESS RELEASE published on 04/07/2026 at 18:00, 1 month ago Uitstel Gewone Algemene Vergadering Oxurion NV kondigt uitstel van de Jaarlijkse Vergadering van Aandeelhouders aan vanwege niet gefinaliseerde jaarrekening. Het bedrijf specialiseert zich in farmaceutische onderaannemers. Gevestigd in Leuven, België Oxurion NV Leuven Uitstel Jaarlijkse Vergadering Farmaceutisch
PRESS RELEASE published on 04/07/2026 at 18:00, 1 month ago Postponement Annual Shareholders Meeting Oxurion NV postpones Annual Shareholders Meeting to June 1st, 2026 due to pending annual accounts. The pharmaceutical outsourcing company specializes in acquiring European subcontractors. Forward-looking statements in press release Forward-looking Statements Postponement Oxurion NV Pharmaceutical Outsourcing European Subcontractors
BRIEF published on 03/19/2026 at 18:35, 1 month 19 days ago Oxurion projette l'acquisition d'une CRO internationale Acquisition Stratégie De Croissance Développement Clinique Oxurion CRO Internationale
BRIEF published on 03/19/2026 at 18:35, 1 month 19 days ago Oxurion Announces Intent to Acquire International CRO Acquisition Clinical Research Pharmaceutical International Expansion Oxurion
BRIEF published on 03/19/2026 at 18:35, 1 month 19 days ago Oxurion annonce son intention d'acquérir une CRO internationale Acquisition Expansion Internationale Recherche Clinique Pharmaceutique Oxurion
BRIEF published on 03/19/2026 at 18:35, 1 month 19 days ago Oxurion plans to acquire an international CRO Growth Strategy Acquisition Clinical Development Oxurion International CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 1 month 19 days ago Oxurion signs a letter of intent for the acquisition of an international CRO Oxurion NV (Euronext Brussels: OXUR) announces the signing of a letter of intent for acquiring an international CRO, strengthening its clinical development strategy Acquisition Clinical Development Euronext Brussels CRO Oxurion NV
PRESS RELEASE published on 03/19/2026 at 18:30, 1 month 19 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
Published on 05/07/2026 at 22:05, 1 hour 21 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 1 hour 21 minutes ago Innodata Reports Record First Quarter 2026 Results
Published on 05/07/2026 at 18:30, 4 hours 56 minutes ago Silver Storm Announces Mobilization of Underground Mine Development Contractors at La Parrilla
Published on 05/07/2026 at 16:35, 6 hours 51 minutes ago Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 23:14, 11 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 1 hour 20 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 2 hours 43 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 4 hours 40 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 18:35, 4 hours 50 minutes ago Seminole Hard Rock Casino Named Official Miami World Cup 2026™ Host City Supporter
Published on 05/07/2026 at 19:15, 4 hours 11 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 4 hours 11 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 4 hours 20 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 4 hours 20 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 4 hours 26 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
